Tested Applications
| Positive WB detected in | human plasma tissue |
| Positive IHC detected in | human tonsillitis tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF-P detected in | human tonsillitis tissue |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:2000-1:10000 |
| Immunohistochemistry (IHC) | IHC : 1:400-1:3200 |
| Immunofluorescence (IF)-P | IF-P : 1:200-1:800 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
16489-1-AP targets human IgD in WB, IHC, IF-P, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag9614 Product name: Recombinant human IGHD protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 202-548 aa of BC021276 Sequence: RRDSYYMTSSQLSTPLQQWRQGEYKCVVQHTASKSKKEIFRWPESPKAQASSVPTAQPQAEGSLAKATTAPATTRNTGRGGEEKKKEKEKEEQEERETKTPECPSHTQPLGVYLLTPAVQDLWLRDKATFTCFVVGSDLKDAHLTWEVAGKVPTGGVEEGLLERHSNGSQSQHSRLTLPRSLWNAGTSVTCTLNHPSLPPQRLMALREPAAQAPVKLSLNLLASSDPPEAASWLLCEVSGFSPPNILLMWLEDQREVNTSGFAPARPPPQPGSTTFWAWSVLRVPAPPSPQPATYTCVVSHEDSRTLLNASRSLEVSYLAMTPLIPQSKDENSDDYTTFDDVGSLWT Predict reactive species |
| Full Name | immunoglobulin heavy constant delta |
| Calculated Molecular Weight | 573 aa, 63 kDa |
| Observed Molecular Weight | 55-70 kDa |
| GenBank Accession Number | BC021276 |
| Gene Symbol | IGHD |
| Gene ID (NCBI) | 3495 |
| RRID | AB_2878264 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
IgD is the major antigen receptor isotype on the surface of most peripheral B-cells, where it is coexpressed with IgM. The membrane-bound IgD (mIgD) induces the phosphorylation of CD79A and CD79B by the Src family of protein tyrosine kinases. This antibody recognize the heavy chain (~70 kDa) of IgD.
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for human IgD antibody 16489-1-AP | Download protocol |
| IHC protocol for human IgD antibody 16489-1-AP | Download protocol |
| WB protocol for human IgD antibody 16489-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The human IgD Polyclonal antibody (Cat# 16489-1-AP) has 1 total citation. It was cited in Molecular Therapy (Impact Factor 11.4), a 2024 study by Timothy J. Smith et al. The research field is gene therapy, specifically investigating engineered IgM and IgG cleaving enzymes to mitigate antibody neutralization and complement activation in AAV gene transfer. The antibody was used for Western blot (WB).
| Species | Application | Title |
|---|---|---|
Mol Ther Engineered IgM and IgG cleaving enzymes for mitigating antibody neutralization and complement activation in AAV gene transfer |







